Table of Contents Europe Biopharmaceuticals Market Report 2012-2023 1 Biopharmaceuticals Overview 1.1 Product Overview and Scope of Biopharmaceuticals 1.2 Classification of Biopharmaceuticals by Product Category 1.2.1 Europe Biopharmaceuticals Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Biopharmaceuticals Sales (K Units) Market Share by Types in 2017 1.2.3 Monoclonal Antibodies 1.2.4 Interferon 1.2.5 Colony-Stimulating Factor 1.2.6 Erythropoietin 1.2.7 Insulin 1.2.8 Vaccines 1.2.9 ????Growth Hormones 1.2.10 ????Others 1.3 Europe Biopharmaceuticals Market by Application/End Users 1.3.1 Europe Biopharmaceuticals (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Others 1.4 Europe Biopharmaceuticals Market by Region 1.4.1 Europe Biopharmaceuticals Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Biopharmaceuticals (2012-2023) 1.5.1 Europe Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Biopharmaceuticals 2.2 Raw Material Analysis of Biopharmaceuticals 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Biopharmaceuticals 2.4 Other Costs Analysis of Biopharmaceuticals 2.5 Manufacturing Cost Structure Analysis of Biopharmaceuticals 2.6 Manufacturing Process Analysis of Biopharmaceuticals 2.7 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Biopharmaceuticals Players/Suppliers Profiles and Sales Data 3.1 Roche 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Biopharmaceuticals Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Roche Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Roche Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Roche Biopharmaceuticals Volume in Different Applications and Its Application Share 3.2 Amgen 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Biopharmaceuticals Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Amgen Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Amgen Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Amgen Biopharmaceuticals Volume in Different Applications and Its Application Share 3.3 AbbVie 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Biopharmaceuticals Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 AbbVie Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 AbbVie Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 AbbVie Biopharmaceuticals Volume in Different Applications and Its Application Share 3.4 Sanofi-Aventis 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Biopharmaceuticals Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Sanofi-Aventis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Sanofi-Aventis Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Sanofi-Aventis Biopharmaceuticals Volume in Different Applications and Its Application Share 3.5 Johnson & Johnson 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Biopharmaceuticals Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Johnson & Johnson Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Johnson & Johnson Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Johnson & Johnson Biopharmaceuticals Volume in Different Applications and Its Application Share 3.6 Pfizer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Biopharmaceuticals Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Pfizer Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Pfizer Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Pfizer Biopharmaceuticals Volume in Different Applications and Its Application Share 3.7 Novo Nordisk 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Biopharmaceuticals Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Novo Nordisk Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Novo Nordisk Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Novo Nordisk Biopharmaceuticals Volume in Different Applications and Its Application Share 3.8 Eli Lilly 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Biopharmaceuticals Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Eli Lilly Biopharmaceuticals Volume in Different Applications and Its Application Share 3.9 Novartis 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Biopharmaceuticals Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Novartis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Novartis Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Novartis Biopharmaceuticals Volume in Different Applications and Its Application Share 3.10 Merck 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Biopharmaceuticals Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Merck Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Merck Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Merck Biopharmaceuticals Volume in Different Applications and Its Application Share 4 Europe Biopharmaceuticals Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Biopharmaceuticals Market Competition by Players/Manufacturers 4.1.1 Europe Biopharmaceuticals Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Biopharmaceuticals Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Biopharmaceuticals Sales and Revenue by Type 4.2.1 Europe Biopharmaceuticals Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Biopharmaceuticals Sales and Revenue by Application 4.3.1 Europe Biopharmaceuticals Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Biopharmaceuticals Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Biopharmaceuticals Sales (K Units) by Application 5 Germany Biopharmaceuticals (Sales, Revenue and Price) 5.1 Germany Biopharmaceuticals Sales and Value (2012-2017) 5.1.1 Germany Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Biopharmaceuticals Revenue and Growth Rate (2012-2017) 5.1.3 Germany Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Biopharmaceuticals Sales (K Units) and Market Share by Type 5.3 Germany Biopharmaceuticals Sales (K Units) and Market Share by Application 6 UK Biopharmaceuticals (Sales, Revenue and Price) 6.1 UK Biopharmaceuticals Sales and Value (2012-2017) 6.1.1 UK Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Biopharmaceuticals Revenue and Growth Rate (2012-2017) 6.1.3 UK Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Biopharmaceuticals Sales (K Units) and Market Share by Type 6.3 UK Biopharmaceuticals Sales (K Units) and Market Share by Application 7 France Biopharmaceuticals (Sales, Revenue and Price) 7.1 France Biopharmaceuticals Sales and Value (2012-2017) 7.1.1 France Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Biopharmaceuticals Revenue and Growth Rate (2012-2017) 7.1.3 France Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Biopharmaceuticals Sales (K Units) and Market Share by Type 7.3 France Biopharmaceuticals Sales (K Units) and Market Share by Application 8 Russia Biopharmaceuticals (Sales, Revenue and Price) 8.1 Russia Biopharmaceuticals Sales and Value (2012-2017) 8.1.1 Russia Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Biopharmaceuticals Revenue and Growth Rate (2012-2017) 8.1.3 Russia Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Biopharmaceuticals Sales (K Units) and Market Share by Type 8.3 Russia Biopharmaceuticals Sales (K Units) and Market Share by Application 9 Benelux Biopharmaceuticals (Sales, Revenue and Price) 9.1 Benelux Biopharmaceuticals Sales and Value (2012-2017) 9.1.1 Benelux Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Biopharmaceuticals Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Biopharmaceuticals Sales (K Units) and Market Share by Type 9.3 Benelux Biopharmaceuticals Sales (K Units) and Market Share by Application 10 Italy Biopharmaceuticals (Sales, Revenue and Price) 10.1 Italy Biopharmaceuticals Sales and Value (2012-2017) 10.1.1 Italy Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Biopharmaceuticals Revenue and Growth Rate (2012-2017) 10.1.3 Italy Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Biopharmaceuticals Sales (K Units) and Market Share by Type 10.3 Italy Biopharmaceuticals Sales (K Units) and Market Share by Application 11 Spain Biopharmaceuticals (Sales, Revenue and Price) 11.1 Spain Biopharmaceuticals Sales and Value (2012-2017) 11.1.1 Spain Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Biopharmaceuticals Revenue and Growth Rate (2012-2017) 11.1.3 Spain Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Biopharmaceuticals Sales (K Units) and Market Share by Type 11.3 Spain Biopharmaceuticals Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Biopharmaceuticals Market Forecast (2018-2023) 13.1 Europe Biopharmaceuticals Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Biopharmaceuticals Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Biopharmaceuticals Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Biopharmaceuticals Price and Trend Forecast (2018-2023) 13.2 Europe Biopharmaceuticals Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Biopharmaceuticals Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Biopharmaceuticals Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Biopharmaceuticals Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Biopharmaceuticals Sales Forecast by Type (2018-2023) 13.3.2 Europe Biopharmaceuticals Revenue Forecast by Type (2018-2023) 13.3.3 Europe Biopharmaceuticals Price Forecast by Type (2018-2023) 13.4 Europe Biopharmaceuticals Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Biopharmaceuticals Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Biopharmaceuticals Sales (K Units) by Application (2016-2023) Figure Product Picture of Biopharmaceuticals Table Europe Biopharmaceuticals Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Biopharmaceuticals Sales (K Units) Market Share by Types in 2017 Figure Monoclonal Antibodies Picture Figure Interferon Picture Figure Colony-Stimulating Factor Picture Table Europe Biopharmaceuticals Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Biopharmaceuticals by Applications in 2017 Figure Tumor Picture Figure Diabetes Picture Figure Cardiovascular Picture Table Europe Market Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure France Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2023) Figure Europe Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Biopharmaceuticals Table Industry News List of Biopharmaceuticals Figure Industry Chain Structure of Biopharmaceuticals Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Biopharmaceuticals in 2017 Figure Manufacturing Process Analysis of Biopharmaceuticals Table Raw Materials Sources of Biopharmaceuticals Major Manufacturers Europe Table Major Buyers of Biopharmaceuticals Table Roche Basic Information List Table Roche Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Roche Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Roche Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Roche Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Roche Biopharmaceuticals Volume in Tumor and Its Application Share Table Roche Biopharmaceuticals Volume in Diabetes and Its Application Share Table Roche Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Amgen Basic Information List Table Amgen Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Amgen Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Amgen Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen Biopharmaceuticals Volume in Tumor and Its Application Share Table Amgen Biopharmaceuticals Volume in Diabetes and Its Application Share Table Amgen Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table AbbVie Basic Information List Table AbbVie Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AbbVie Biopharmaceuticals Sales Growth Rate (2012-2017) Figure AbbVie Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure AbbVie Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AbbVie Biopharmaceuticals Volume in Tumor and Its Application Share Table AbbVie Biopharmaceuticals Volume in Diabetes and Its Application Share Table AbbVie Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Sanofi-Aventis Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Biopharmaceuticals Volume in Tumor and Its Application Share Table Sanofi-Aventis Biopharmaceuticals Volume in Diabetes and Its Application Share Table Sanofi-Aventis Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Johnson & Johnson Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Johnson & Johnson Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Biopharmaceuticals Volume in Tumor and Its Application Share Table Johnson & Johnson Biopharmaceuticals Volume in Diabetes and Its Application Share Table Johnson & Johnson Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Pfizer Basic Information List Table Pfizer Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Pfizer Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Pfizer Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Biopharmaceuticals Volume in Tumor and Its Application Share Table Pfizer Biopharmaceuticals Volume in Diabetes and Its Application Share Table Pfizer Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Novo Nordisk Basic Information List Table Novo Nordisk Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novo Nordisk Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Novo Nordisk Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Novo Nordisk Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novo Nordisk Biopharmaceuticals Volume in Tumor and Its Application Share Table Novo Nordisk Biopharmaceuticals Volume in Diabetes and Its Application Share Table Novo Nordisk Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Eli Lilly Basic Information List Table Eli Lilly Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Eli Lilly Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Eli Lilly Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly Biopharmaceuticals Volume in Tumor and Its Application Share Table Eli Lilly Biopharmaceuticals Volume in Diabetes and Its Application Share Table Eli Lilly Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Novartis Basic Information List Table Novartis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Novartis Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Novartis Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Biopharmaceuticals Volume in Tumor and Its Application Share Table Novartis Biopharmaceuticals Volume in Diabetes and Its Application Share Table Novartis Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Company Merck Basic Information List Table Company Merck Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Merck Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Company Merck Biopharmaceuticals Sales Europe Market Share (%) (2012-2017) Figure Company Merck Biopharmaceuticals Revenue Europe Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Merck Biopharmaceuticals Volume in Tumor and Its Application Share Table Company Merck Biopharmaceuticals Volume in Diabetes and Its Application Share Table Company Merck Biopharmaceuticals Volume in Cardiovascular and Its Application Share Table Europe Biopharmaceuticals Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Biopharmaceuticals Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Biopharmaceuticals Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Biopharmaceuticals Sales Share by Players/Manufacturers Table Europe Biopharmaceuticals Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Biopharmaceuticals Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Biopharmaceuticals Revenue Market Share (%) Players Figure 2017 Europe Biopharmaceuticals Revenue Market Share (%) Players Table Europe Biopharmaceuticals Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Biopharmaceuticals Sales Share by Type (2012-2017) Figure Sales Market Share of Biopharmaceuticals by Type (2012-2017) Figure Europe Biopharmaceuticals Sales Growth Rate (%) by Type (2012-2017) Table Europe Biopharmaceuticals Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Biopharmaceuticals Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Biopharmaceuticals by Type (2012-2017) Figure Europe Biopharmaceuticals Revenue Growth Rate by Type (2012-2017) Table Europe Biopharmaceuticals Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Biopharmaceuticals Sales Share by Regions (2012-2017) Figure Sales Market Share of Biopharmaceuticals by Regions (2012-2017) Figure Europe Biopharmaceuticals Sales Market Share by Regions in 2017 Table Europe Biopharmaceuticals Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Biopharmaceuticals Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Biopharmaceuticals by Regions (2012-2017) Figure Europe Biopharmaceuticals Revenue Market Share by Regions in 2017 Table Europe Biopharmaceuticals Sales (K Units) and Market Share by Application (2012-2017) Table Europe Biopharmaceuticals Sales Share (%) by Application (2012-2017) Figure Europe Biopharmaceuticals Sales Market Share by Application (2012-2017) Figure Europe Biopharmaceuticals Sales Market Share by Application (2012-2017) Figure Germany Biopharmaceuticals Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Germany Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Germany Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Germany Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Germany Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Germany Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure UK Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure UK Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table UK Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table UK Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure UK Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table UK Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table UK Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure UK Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure France Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure France Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table France Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table France Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure France Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table France Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table France Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure France Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure Russia Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure Russia Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Russia Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Russia Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Russia Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Russia Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Russia Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure Italy Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure Italy Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Italy Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Italy Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Italy Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Italy Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Italy Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure Benelux Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Benelux Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Benelux Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Benelux Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure Spain Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure Spain Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Spain Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Spain Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Spain Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Spain Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Spain Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Biopharmaceuticals Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Biopharmaceuticals Price and Trend Forecast (2018-2023) Table Europe Biopharmaceuticals Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Biopharmaceuticals Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Biopharmaceuticals Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Biopharmaceuticals Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Biopharmaceuticals Revenue Market Share Forecast by Regions in 2023 Figure Germany Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Biopharmaceuticals Sales (K Units) Forecast by Type (2018-2023) Figure Europe Biopharmaceuticals Sales Market Share Forecast by Type (2018-2023) Table Europe Biopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Biopharmaceuticals Revenue Market Share Forecast by Type (2018-2023) Table Europe Biopharmaceuticals Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Biopharmaceuticals Sales (K Units) Forecast by Application (2018-2023) Figure Europe Biopharmaceuticals Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck